Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Vitamin D Levels of COVID-19 Positive Sypmtomatic Pediatric Cases
Söbü et al., The Journal of Current Pediatrics, doi:10.4274/jcp.2021.0002
Söbü et al., Vitamin D Levels of COVID-19 Positive Sypmtomatic Pediatric Cases, The Journal of Current Pediatrics, doi:10.4274/jcp.2021.0002
Feb 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 30 hospitalized pediatric COVID-19 patients and 82 healthy controls, showing significantly lower vitamin D levels in COVID-19 patients.
Söbü et al., 2 Feb 2021, peer-reviewed, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Söbü et al. COVID-19 and Vitamin D The Journal of Current Pediatrics Güncel Pediatri ORIGINAL ARTICLE ÖZGÜN ARAŞTIRMA Vitamin D Levels of COVID-19 Positive Sypmtomatic Pediatric Cases COVID-19 Pozitif Semptomatik Çocukların D Vitamini Düzeyleri Elif Söbü (0000-0002-2037-7046), Ayşe Karaaslan (0000-0003-4289-3321), Ceren Çetin (0000-0001-6423-7523), Yasemin Akın (0000-0002-7618-7778) University of Health Sciences Turkey, İstanbul Kartal Dr. Lütfi Kırdar City Hospital, Clinic of Pediatrics and Medicine, Istanbul, Turkey Abstract Keywords COVID-19, vitamin D, hypophosphatemia Anah­tar ke­li­me­ler COVID-19, D vitamini, hipofosfatemi Received/Geliş Ta­rihi : 21.12.2020 Accepted/Ka­bul Ta­ri­hi : 02.02.2021 DOI:10.4274/jcp.2021.0002 Ad­dress for Cor­res­pon­den­ce/Ya­zış­ma Ad­re­si (Sorumlu Yazar): Elif Söbü, Sağlık Bilimleri Üniversitesi, İstanbul Kartal Dr. Lütfi Kırdar Şehir Hastanesi, Çocuk Sağlığı ve Hastalıkları, İstanbul, Türkiye J Curr Pediatr 2021;19:9-14 Introduction:Vitamin D is known as a vitamin but also it acts as a prohormone and has many functions. The aim of this study is to investigate the vitamin D levels in pediatric patients with COVID-19. Materials and Methods: A retrospective study was performed in a tertiary education and research hospital in Istanbul, Turkey during the period of Marcht o April 2020. Children diagnosed with symptomatic COVID-19 infection were included in the study. Demographic, clinical and laboratory findings were recorded from patient charts retrospectively. All patients investigated for vitamin D levels. Control group consists of healthy children admitted to pediatric outpatient units for routine check-up in the same season.Thirty children with COVID-19 and 82 healthy children included in this study were compared due to 25-OH vitamin D levels. Results: The median age of COVID-19 positive patients was 11.8 (1.8-17.6) years and the median age of control group was 12.7 (1-16.4) years old. There were 15 (50%) females and 15 (50%) males in infected group and there were 39 (47.5%) females and 43 (52.5%) males control group. Age and gender did not differ among the groups. Median vitamin D level in COVID-19 positive group was 8.9 ng/ml (342 ng/ml) and 18.5 ng/ml (9-40.7 ng/ml) in control group. We detected significantly lower vitamin D values in COVID19(+) group when compared with control group (p<0.001). CT was performed 19 patients in COVID-19 positive group and viral pneumonia was detected in 12(63%) of 19. pneumonia (+) group a 17.4-years-old female patient and a 13.1-years-old male patient had low phosphorus levels by age (2.2 and 2.4 mg/dl). Both of them needed high flow oxygen therapy. None of the other cases needed oxygen therapy. Conclusions: This is the first study to date has measured vitamin D levels in children with COVID-19 in Turkey. We detected significantly lower vitamin D values in COVID-19(+) hospitalized children. Öz Giriş: D vitamini bir vitamin olarak bilinmesine rağmen aynı zamanda bir prohormon görevi görür ve birçok işlevi vardır. Çalışmamızda COVID-19 enfeksiyonu tanısı ile izlenen pediyatrik hastalarda D vitamini düzeylerinin değerlendirilmesi amaçlandı. Gereç ve Yöntem: Çalışmamız Mart-Nisan 2020 tarihlerinde İstanbul’da bir 3. basamak eğitim ve araştırma hastanesinde gerçekleştirildi. Semptomatik COVID-19 enfeksiyonu tanısı alan çocuklar çalışmaya dahil edildi. Demografik, klinik ve laboratuvar bulgular retrospektif olarak hasta dosyalarından kaydedildi. Tüm..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit